The Effect Of Ocrelizumab On Lymphocytes In Multiple Sclerosis Patients Previously Exposed To Lymphocyte Altering Agents
Posted Date: May 15, 2019
- Investigator: Aram Zabeti
- Type of Study: Observational/Survey
Ocrelizumab Observational - Marcucci
Criteria:
You Are Being Asked To Take Part In This Research Study Because You Are Between The Ages Of 18 And 5
Keywords:
None
For More Information:
Molly Winters
513-558-0269
molly.winters@uc.edu